Catalyst Wire Dossier Catalyst Wire Dossier

REXTOVY

Naloxone hydrochloride · International Medication Systems, Ltd.
Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for REXTOVY, covering 2023-03-07 to 2026-06-16. Get the full timeline:

Most recent: FDA Approved: REXTOVY — Supplemental Application (International Medication Systems, Ltd.)

See pricing